This observational study is looking at how aromatase inhibitor therapy, a common breast cancer treatment, affects skin quality and self-esteem in women who have had breast cancer. Researchers will use special imaging technology (Canfield Sciences VISIA-CA) and facial photographs to measure changes in your skin. They will also ask you to complete surveys about your self-esteem and how skin changes affect your daily life. The study aims to see if skincare advice from an aesthetician can improve skin quality and how you feel about yourself. This study is for postmenopausal women (ages 18 and older) with certain types of breast cancer (stages 0-III) that are estrogen receptor (ER) and/or progesterone receptor (PR) positive. The study plans to enroll 35 participants and will measure changes in skin quality for up to 6 months.

Study design

This is an observational study involving about 35 women. It does not involve a new treatment but rather observes the effects of existing aromatase inhibitor therapy.

What's involved

You would complete surveys, have your skin measured with a special device, have facial photographs taken, and attend consultations with an aesthetician.

Compensation

Not stated in the trial record.

Follow-up

Skin quality changes will be measured for up to 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.